[Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
作者信息
Grebnev A L, Miagkova L P, Kkhorshed A M
出版信息
Klin Med (Mosk). 1991 Mar;69(3):23-7.
PMID:1676772
Abstract
摘要
相似文献
1
2
[Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
Klin Med (Mosk). 1991 Mar;69(3):27-34.
3
4
Histamine H2-receptor antagonists.组胺H2受体拮抗剂
Nurs Clin North Am. 1991 Jun;26(2):361-73.
5
6
[Current viewpoints in the pathogenesis and therapy of peptic ulcer].[消化性溃疡发病机制与治疗的当前观点]
Ned Tijdschr Geneeskd. 1987 Oct 10;131(41):1799-802.
7
[Mechanism of recurrence and relapse in peptic ulcer after drug therapy; gastric juice and gastric acid secretion].[药物治疗后消化性溃疡复发和再发的机制；胃液及胃酸分泌]
Nihon Rinsho. 1988 Jan;46(1):102-6.
8
[Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
Ned Tijdschr Geneeskd. 1989 Apr 1;133(13):657-62.
9
[Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].[用于消化性溃疡治疗的药物，特别提及H2受体阻滞剂]
Clin Ter. 1989 Apr 15;129(1):3-16.
10
Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost.
Postgrad Med. 1994 Nov 1;96(6):53-9.
Zotero 插件